A Critique The Good and Bad of A Review
A Critique The Good and Bad of A Review
A Critique The Good and Bad of A Review
net/publication/283616667
CITATIONS READS
0 16,813
3 authors, including:
Rhett Mcclean
Charles Sturt University
17 PUBLICATIONS 207 CITATIONS
SEE PROFILE
Some of the authors of this publication are also working on these related projects:
All content following this page was uploaded by Rhett Mcclean on 06 February 2018.
School of Biomedical Sciences, Charles Sturt University, Bathurst, NSW 2795, Australia
ABSTRACT
Evidence based medicine involves using both the individual clinician’s expertise and the current best
available external clinical evidence from systematic research in deciding on the appropriate care for
individual patients. The current approach to evidence based practice in healthcare adds a third component
which is patient values. Evidence based practice is thus a triad, in which the practitioner’s expertise,
research evidence and the patient’s values are all given consideration. The balance to be struck between
them depends on the individual case. The literature indicates that complementary medicine practitioners
are moving away from traditional knowledge and towards the use of evidence based practice in their
clinical discussions. In the context of the daily practice of complementary medicine practitioners and their
continuing development of their knowledge base of evidence based practice, this short review discusses
the good and bad of a review journal article.
the topic of the study and should catch the attention of the of research in complementary medicine (Ernst et al., 2004), this
reader to enable them to determine the relativity of the topic review’s inclusion of research mostly from the past ten years is
and/or interest to either inspire them to read or reject it reasonable. Generally, study design is the main measure of
(Caldwell et al., 2005; Marshall, 2005). In Yuan’s paper the title validity of the findings. Within this context, the hierarchy of
accurately reflects the focus of the paper, green tea and cancer evidence is the most widely used grading system placing
prevention, together with the words ‘evidence from studies in order of scientific rigor (Ho et al., 2008). For
epidemiologic studies’ indicating other publications are example, expert opinion is relegated to the bottom of the
summarized in this review, therefore allowing the reader to hierarchy because it is has the most risk of bias, therefore, more
interpret the content of the study and enable data bases to prone to threats of internal validity and therefore providing the
include the review in search results; an unclear or confusing weakest evidence. Systematic review, meta-analysis and
title can mislead the reader (Caldwell et al., 2011). According randomized controlled trials (RCTs) are considered least prone
to Green et al. (2006), an abstract should present a brief to bias, have the most sound design providing the strongest
summary of the main components including the aim and/or evidence, accordingly, are top of the hierarchy (Hess, 2004;
objective of the study, methodology and main findings. MeInyk and Fineout-Overholt, 2011). Yuan’s review includes
Marshall (2005) concurs by adding that readers use an abstract mostly quality evidence, according to the evidence hierarchy,
to judge its relevance to their particular needs. In Yuan’s review and includes large cohort studies, randomized, placebo-
the abstract is brief, summarizing the content. However, there is controlled trials including several phase 2 clinical trials, several
no clear or specific statement of aims and/or objectives meta analyses and systematic reviews, and a couple of case
presented in this review which is a critical factor to focus the studies. Case studies can provide information not always
study and clearly identify what the research is attempting to reported in other studies such as clinical trials and can add to a
achieve (Marshall, 2005). Boswell and Cannon (2014) note that practitioner’s knowledge (MeInyk and Fineout-Overholt, 2011).
in qualitative research a broad question rather than an
hypothesis is usual. The closest to, but far from, a statement of
aim is found in the introduction ‘the results of green tea Critical appraisal
consumption on the protection/risk of various cancer sites in
humans assessed here are’. After reading Yuan’s abstract the Yuan’s paper is categorized into the specific cancers and their
reader has to assume the aims but does get a general idea of the relevant studies. Within the categories each study reviewed has
direction of the review. This contrasts with the Hou et al. (2013) a brief description, results, discussion and recommendations
study which makes a very clear statement about the aim of their with an overall analysis, main findings and recommendation for
study with ‘The aim of this systematic and up-to-date review each cancer. A review should not just describe the studies
was to critically evaluate all epidemiological studies published included, but make a critical appraisal (Marshall, 2005). Yuan
so far to report an association between green tea consumption has given a critical examination, such as evidenced by noting in
and GC risk’. Yuan does, however, provide a foundation for the esophageal cancer that the inconsistencies in results across
review, noting previous research in animal models consistently studies may be due to confounding effects, particularly in Asian
showed positive results in prevention in contrast to the mixed populations where there are high rates of this cancer as well as
results in human studies so far. According to Caldwell et al. high consumption of hot green tea. Further, noting the
(2011), the research should be placed in context by presenting a association between green tea consumption and a greater
rationale for the research within current knowledge of the focus likelihood of smoking and alcohol. To clarify any association
topic. Hence, the title and abstract should correctly represent between green tea and esophageal cancer, Yuan recommends
the paper. The abstract identifies the cancers included in the studies controlling these factors. Study descriptions are,
review as oral/digestive tract cancers (oral, esophageal, gastric, however, inconsistent. For example, the study sample
colorectal), liver, lung, prostate and breast cancers and a brief populations are included for some Chinese and Japanese
overview of the study types used has been identified here, for populations, and not for others. It is important to clarify the
some cancers. A very brief summary of findings for each cancer sample population in order for the reader to decide if the
is included in the abstract with the main findings of the review research is relevant to their agenda (Boswell and Cannon,
reported as well as recommendations for further research. 2014). Further, data such as relative risk and confidence
Therefore, given the information included in the abstract, it intervals appropriate for study types such as RCTs and cohort
basically conforms to what is expected in an abstract of a studies were not reported for all (MeInyk and Fineout-Overholt,
narrative review except for the important statement of aims 2011). Therefore, the reader is unable to make fair comparisons
and/or objectives and omission of methodology not usually between studies. A summary table of the data would improve
included in a narrative review (Caldwell et al., 2011; Green et the review by ensuring all relevant data is included promoting
al., 2006). clarity, making it easy and fast for the reader to assimilate the
data without having to refer to the article as was presented in
the Hou et al. (2013).
Sources, relevance and rigour of studies included in a
review
A good conclusion
The quality of a paper is a reflection of the relevance, recency
and design of studies used including whether primary or Boswell and Cannon (2014), and Caldwell et al. (2011) concur
secondary sources are used (Ho et al., 2008; Marshall, 2005). that conclusions must be based on the results of the included
As the author has a considerable amount of previously studies and should not make exaggerated claims. Further, that
published research on this topic, it would be remiss to exclude author recommendations for future study often arise from the
them, however, it is a matter of perspective in considering if conclusions (Marshall, 2005). The evidence provided in this
they are primary or secondary studies, although technically review supports Yuan’s conclusions confirming green tea as a
they are secondary. The literature included should be up-to-date preventative in cancer in humans is inconclusive, in contrast to
and comprehensive (Caldwell et al., 2011). Given the paucity strong positive animal studies. However, he does surmise from
Health professionals need to recognize that the synthesis of Creswell JW. Qualitative inquiry and research design:
information in a narrative review is the author’s interpretation Choosing among five approaches. 3rd ed. (Los Angeles, USA:
and that another review will not necessarily return the same Sage Publications Inc), 2013.
results (Webb and Roe, 2007). In evidence based practice, the
best available evidence with the least likelihood of bias should Ernst E, Cohen MH, Stone J. Ethical problems arising in
be used in guiding clinical decisions (MeInyk and Fineout- evidence based complementary and alternative medicine. J
Overholt, 2011). From a complementary medicine practitioner Med Ethics. 2004;30:156-159.
perspective, as a multidisciplinary profession, evidence comes
from various research approaches and strengths of evidence Green BN, Johnson CD, Adams A. Writing narrative literature
(Caldwell et al., 2005). Due to the interpretive character of reviews for peer-reviewed journals: secrets of the trade. J
narrative reviews, the broader perspective of the topic rather Chiropr Med. 2006;5:101-117.
than a clinical focus and lack of systematic approach, Yuan’s
review should not be considered strong evidence on which to Hess DR. What is evidence-based medicine and why should I
base clinical decisions. However, it is useful for keeping up-to- care? Respir Care. 2004;49:730-741.
date with the research topic and to prompt further
investigation/reading (Green et al., 2006; Webb and Roe, 2007). Ho MP, Peterson PN, Masoudi FA. Evaluating the evidence: is
there a rigid hierarchy? Circulation. 2008;118:1675-1684.
ACKNOWLEDGEMENTS Hou IC, Amarnani S, Chong MT, Bishayee A. Green tea and
the risk of gastric cancer: epidemiological evidence. World J
None. Gastroenterol. 2013;19:3713-3722.
Boswell C, Cannon S. Critique process. In: Introduction to Yuan JM. Cancer prevention by green tea: Evidence from
nursing research: Incorporating evidence based practice. epidemiologic studies. Am J Clin Nutr. 2013;98:1676S-1681S.
Boswell C, Cannon S, editors. 3rd ed. (Burlington, USA: Jones
and Bartlett Learning), pp. 291-309, 2014.